RxDoctor Payments Data

Nathan Blessing, MD

Ophthalmology · Palm Beach Gardens, FLNPI 1104186808

Payments from drug & device makers

$2,553in general payments, 2019–2025

Across 30 payments — averaging $85.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$357
  • Mallinckrodt Enterprises LLC$132
  • Glaukos Corporation$55
  • Merz North America, Inc.$29
  • Baudax Bio Inc.$25
  • plus $51 from 3 others

What the payments were for

  • Speaking & faculty fees$1,40055%
  • Food & beverage$1,12444%
  • Education$291%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen16$1,905
AbbVie(2 entities)6$357
Mallinckrodt Enterprises LLC1$132
Glaukos Corporation1$55
Merz North America, Inc.2$29
Baudax Bio Inc.1$25
Halozyme Inc1$24
Katalyst Surgical, LLC1$15
Galderma Laboratories, L.p.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,553 in reported general payments places this provider in the 55th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida

Medicare billing

Part B allowed, 2024
$216,998
Medicare patients
414
Services billed
2,854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha371$3,654
Prednisolone Acetate11$380
ErythromycinErythromycin Base12$130
ValacyclovirValacyclovir Hcl11$78
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim13$69
Cephalexin11$42

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Palm Beach Gardens

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →